影响因子从3分一路猛涨到15+分！最近4篇文章被曝光疑有问题！
这不，2020年最新IF为15.302的Molecular Cancer，居然翻车了！
什么，你居然还不认识Molecular Cancer？
这涨分速度！
图源：选刊说公众号
发表最多的机构为德州大学(105篇, 4.390%)，其次是中山大学(90篇, 3.763%)，上海交通大学(84篇, 3.512%)，还有我国其他机构均占有一定的比例，如南京医科大学，复旦大学，浙江大学，中科院，南方医科大学等。
Citescore排名顶尖，排名均在97%
图源：选刊说公众号
日前，著名学术打假网站 Pubpeer挂了来自Molecular Cancer的论文，发表单位均来自于国内著名科研单位~~
这好不容易涨到15分的论文呀，突然被打假
━((*′д｀)爻(′д｀*))━!!!!
第一篇
Title：Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis
Affiliations: （中山大学孙逸仙纪念医院）
① Department of Urology and Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107th Yanjiangxi Road, Yuexiu District, Guangzhou 510120, China
质疑：一图多用 （Figure 8e）
回应状态：作者尚未回应
第二篇
Title：CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling
Affiliations: （上海交大附属第六人民医院）
①Department of Gastroenterology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600 Yishan Road, Shanghai, 200233, China.
②Department of Gastroenterology, Shanghai Ninth People's Hospital, Shanghai Jiao ③Tong University School of Medicine, Shanghai, China. ④Department of Gastroenterology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600 Yishan Road, Shanghai, 200233, China.
质疑：Figure 7 appears to have a duplicate image for different cell lines （一图多用）
回应状态：作者已回应，表示将仔细检查论文原始数据
图源： Pubpeer
第三篇
Title：CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p
Affiliations: （南京市第一医院 南京医科大学附属南京医院）
①Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
②Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
③Department of General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
④Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
质疑：Figure 5h appears to use the same image 3 times for different cell lines（一图多用）
回应状态：作者尚未回应
图源： Pubpeer
第四篇
Title：EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis
Affiliations: （中国人民武装警察部队特色医学中心）
①Institute of Traumatic Brain Injury and Neurology, Characteristic Medical Center of Chinese People’s Armed Police Force, Tianjin 300162, China.
②Department of Neurosurgery, Characteristic Medical Center of Chinese People’s Armed Police Force, Tianjin 300162, China.
③Department of Basic Medicine, Tianjin Medical College, Tianjin 300222, China.
④Chinese Glioma Cooperative Group (CGCG), Tianjin, China.
质疑：一图多用；此外，还有如下问题：
① miR-124的引物实际上是CDK4的引物
② AURK的引物是双歧杆菌基因的引物
③ circMMP9的长度应为为312 bp，而此文章中长度居然是540bp！！！
回应状态：作者尚未回应
此外，我们来看看，最近Molecular Cancer发表的一些文章，还是很多是属于非编码RNA：
- RNA的N6-甲基腺苷修饰在人类癌症中的作用机制
Received: 31 January 2020 Accepted: 13 May 2020 Online: 08 June 2020 从投稿到接受3.4个月
- CircTLK1通过刺激miR-136-5p促进肾细胞癌的增殖和转移
Received: 11 November 2019 Accepted: 28 May 2020 Online: 05 June 2020 从投稿到接受6.6个月
- 环状RNA circSATB2促进非小细胞肺癌细胞的进程
Received: 26 August 2019 Accepted: 21 May 2020 Online: 03 June 2020 从投稿到接受9个月
- 环状RNA circMET通过miR-30-5p / snail / DPP4轴驱动肝细胞癌的免疫抑制和抗PD1治疗耐药性
Received: 29 November 2019 Accepted: 07 May 2020 Online: 19 May 2020 从投稿到接受5.3个月
- 发现新型第三代EGFR抑制剂并确定克服其耐药性的潜在联合策略
Received: 26 November 2019 Accepted: 15 April 2020 Online: 13 May 2020 从投稿到接受4.7个月
- LncRNA TROJAN在ER+乳腺癌中通过激活CDK2转录促进细胞增殖和对CDK4/6抑制剂的抵抗
Received: 02 December 2019 Accepted: 27 April 2020 Online: 11 May 2020 从投稿到接受4.9个月 来自：选刊说公众号
截至发稿，目前这几篇文章的作者大部分都未进一步回应，那咱们就静观其变。
